Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction-Reference-Cited by-同舟云学术

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction

Published:2017-08-03 Issue:9 Volume:108 Page:1870-1880
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yamakawa Yasuaki¹,Tazawa Hiroshi²³^ORCID,Hasei Joe¹,Osaki Shuhei¹,Omori Toshinori¹,Sugiu Kazuhisa¹,Komatsubara Tadashi¹,Uotani Kouji¹,Fujiwara Tomohiro¹,Yoshida Aki¹,Kunisada Toshiyuki¹⁴,Urata Yasuo⁵,Kagawa Shunsuke²⁶,Ozaki Toshifumi¹,Fujiwara Toshiyoshi²

Affiliation:

1. Department of Orthopaedic Surgery Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

2. Department of Gastroenterological Surgery Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

3. Center for Innovative Clinical Medicine Okayama University Hospital OkayamaJapan

4. Medical Materials for Musculoskeletal Reconstruction Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences OkayamaJapan

5. Oncolys BioPharma, Inc. TokyoJapan

6. Minimally Invasive Therapy Center Okayama University Hospital Okayama Japan

Funder

Ministry of Education, Science, and Culture, Japan

National Cancer Center Research and Development Fund

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13316

Reference47 articles.